Back to all events
18 Sep 2019
  • Victorian Comprehensive Cancer Centre

Melanoma Biomarker Symposium

Examine the state of the art in biomarkers for melanoma prognosis and prediction of responses to treatment, and the pathway to their implementation in the clinic.

Featuring international guest speaker
Dr Alexander Meves, Mayo Clinic USA

Meves Alexander

Dr. Meves’ clinical interests are related to skin cancer, specifically melanoma. His research focuses on the biology of skin cancer, specifically as it relates to the remodeling of connective tissue and the extracellular matrix. He also aims to translate basic research into new and innovative methods to diagnose and treat skin cancer. For example, he co-developed the SkylineDx CP-GEP model for primary melanoma risk-stratification and works with colleagues at Mayo Clinic and Exact Sciences on ‘liquid biopsy’ diagnostic tests for metastatic melanoma.

Local guest speaker
Professor Maarten IJzerman, University of Melbourne

Professor Maarten IJzerman

Professor IJzerman is leading a global research program focused on the health economics and service delivery of precision medicine, in particular oncology. The research program includes the use of real-world (linked) data for health services research, the use of decision modelling methods for biomarker development, patient-preferences research and dynamic treatment sequencing.

Other speakers include:
  • Dr Mitchell Stark, University of Queensland

  • Dr Andrew Colebatch, University of New South Wales

  • Dr Oliver Klein, Olivia Newton-John Cancer Research Institute

  • Prof Tony Papenfuss, Walter & Eliza Hall Institute and Peter MacCallum Cancer Centre

  • Dr Louise Jackett, Austin Health

  • Dr Jess Duarte, Olivia Newton-John Cancer Research Institute

  • Dr Joseph Cursons, Walter & Eliza Hall Institute and oNKo-innate

  • A/Prof Victoria Mar, Victorian Melanoma Service, Alfred Health

  • A/Prof Alex Dobrovic, Olivia Newton-John Cancer Research Institute

  • Dr Amir Iravani, Peter MacCallum Cancer Centre

  • Dr Inês Silva, Melanoma Institute Australia

Symposium Topics

  • Novel Biomarkers: autoantibodies; ctDNA; microRNA, mutation signatures
  • Predictive Biomarkers: responses to neoadjuvant therapy; response to immunotherapy; immune adverse events
  • Application in Practice: bioinformatics for validation; pathways for novel biomarkers application in the clinic
Download the program

Convened by Dr David Gyorki, VCCC Research & Education Lead in Melanoma & Skin Cancers.

The symposium is presented by the Victorian Comprehensive Cancer Centre in collaboration with Melanoma Research Victoria

Can't attend in person? Register for Webinar